| Ruxolitinib as salvage therapy in steroid-refractory acute graft-versus-host disease in pediatric hematopoietic stem cell transplant patients P Khandelwal, A Teusink-Cross, SM Davies, AS Nelson, CE Dandoy, ... Biology of Blood and Marrow Transplantation 23 (7), 1122-1127, 2017 | 107 | 2017 |
| Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD NJ Gloude, P Khandelwal, N Luebbering, DT Lounder, S Jodele, ... Blood, The Journal of the American Society of Hematology 130 (10), 1259-1266, 2017 | 102 | 2017 |
| Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome AW Lindsley, HM Saal, TA Burrow, RJ Hopkin, O Shchelochkov, ... Journal of Allergy and Clinical Immunology 137 (1), 179-187. e10, 2016 | 93 | 2016 |
| Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease SP Bhatt, P Khandelwal, S Nanda, JC Stoltzfus, GT Fioravanti Respiratory medicine 102 (7), 999-1003, 2008 | 80 | 2008 |
| Experience with alemtuzumab, fludarabine, and melphalan reduced-intensity conditioning hematopoietic cell transplantation in patients with nonmalignant diseases reveals good … RA Marsh, MB Rao, A Gefen, D Bellman, PA Mehta, P Khandelwal, ... Biology of Blood and Marrow Transplantation 21 (8), 1460-1470, 2015 | 74 | 2015 |
| Experience with alemtuzumab, fludarabine, and melphalan reduced-intensity conditioning hematopoietic cell transplantation in patients with nonmalignant diseases reveals good … RA Marsh, MB Rao, A Gefen, D Bellman, PA Mehta, P Khandelwal, ... Biology of Blood and Marrow Transplantation 21 (8), 1460-1470, 2015 | 71 | 2015 |
| Hematopoietic stem cell transplantation activity in pediatric cancer between 2008 and 2014 in the United States: a center for international blood and marrow transplant research … P Khandelwal, HR Millard, E Thiel, H Abdel-Azim, AA Abraham, JJ Auletta, ... Biology of Blood and Marrow Transplantation 23 (8), 1342-1349, 2017 | 70 | 2017 |
| Lower levels of vitamin A are associated with increased gastrointestinal graft-versus-host disease in children DT Lounder, P Khandelwal, CE Dandoy, S Jodele, MS Grimley, ... Blood, The Journal of the American Society of Hematology 129 (20), 2801-2807, 2017 | 59 | 2017 |
| A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant CE Dandoy, S Rotz, PB Alonso, A Klunk, C Desmond, J Huber, ... Blood advances 5 (1), 1-11, 2021 | 48 | 2021 |
| Bortezomib for refractory autoimmunity in pediatrics P Khandelwal, SM Davies, MS Grimley, MB Jordan, BR Curtis, S Jodele, ... Biology of Blood and Marrow Transplantation 20 (10), 1654-1659, 2014 | 48 | 2014 |
| Risk factors for graft-versus-host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide A Im, A Rashidi, T Wang, M Hemmer, ML MacMillan, J Pidala, M Jagasia, ... Biology of blood and marrow transplantation 26 (8), 1459-1468, 2020 | 41 | 2020 |
| Cytokine profile of engraftment syndrome in pediatric hematopoietic stem cell transplant recipients P Khandelwal, S Mellor-Heineke, N Rehman, A Lane, K Smiley, ... Biology of Blood and Marrow Transplantation 22 (4), 690-697, 2016 | 35 | 2016 |
| Peripheral blood CD38 bright CD8+ effector memory T cells predict acute graft-versus-host disease P Khandelwal, A Lane, V Chaturvedi, E Owsley, SM Davies, D Marmer, ... Biology of Blood and Marrow Transplantation 21 (7), 1215-1222, 2015 | 32 | 2015 |
| Single ultra-high-dose cholecalciferol to prevent vitamin D deficiency in pediatric hematopoietic stem cell transplantation G Wallace, S Jodele, KC Myers, CE Dandoy, J El-Bietar, A Nelson, ... Biology of Blood and Marrow Transplantation 24 (9), 1856-1860, 2018 | 30 | 2018 |
| A prospective study of alemtuzumab as a second-line agent for steroid-refractory acute graft-versus-host disease in pediatric and young adult allogeneic hematopoietic stem cell … P Khandelwal, C Emoto, T Fukuda, AA Vinks, L Neumeier, CE Dandoy, ... Biology of Blood and Marrow Transplantation 22 (12), 2220-2225, 2016 | 27 | 2016 |
| CD38brightCD8+ T cells associated with the development of acute GVHD are activated, proliferating, and cytotoxic trafficking cells P Khandelwal, V Chaturvedi, E Owsley, A Lane, D Heyenbruch, ... Biology of Blood and Marrow Transplantation 26 (1), 1-6, 2020 | 24 | 2020 |
| Pretransplant absolute lymphocyte counts impact the pharmacokinetics of alemtuzumab RA Marsh, T Fukuda, C Emoto, L Neumeier, P Khandelwal, S Chandra, ... Biology of Blood and Marrow Transplantation 23 (4), 635-641, 2017 | 24 | 2017 |
| A single-center experience comparing alemtuzumab, fludarabine, and melphalan reduced-intensity conditioning with myeloablative busulfan, cyclophosphamide, and antithymocyte … P Khandelwal, JJ Bleesing, SM Davies, RA Marsh Biology of Blood and Marrow Transplantation 22 (11), 2011-2018, 2016 | 24 | 2016 |
| Graft-versus-host disease prophylaxis with abatacept reduces severe acute graft-versus-host disease in allogeneic hematopoietic stem cell transplant for beta-thalassemia major … P Khandelwal, RF Yeh, L Yu, A Lane, CE Dandoy, J El-Bietar, SM Davies, ... Transplantation 105 (4), 891-896, 2021 | 21 | 2021 |
| Experience with a reduced toxicity allogeneic transplant regimen for non-CGD primary immune deficiencies requiring myeloablation S Chandra, S Chandrakasan, BJ Dávila Saldaña, JJ Bleesing, MB Jordan, ... Journal of clinical immunology 41, 89-98, 2021 | 20 | 2021 |
